Read our latest Nanopinion guest column from Dr Dorota Napierska, Health Care Without Harm Europe who talks about the benefits and risks of using nanosilver as an antimicrobial agent in clinical settings.
"During the pandemic, antimicrobial impregnated products are increasingly being offered up as an added tool to reduce the burden of Coronaviruses such as COVID19 – companies are not only offering these products to hospitals, but also direct to consumers. The purported specific advantage of a biocide treatment is frequently questionable."
Read the full text
Nanopinion is a platform where EUON invites views from different contributors ranging from policy-makers and authorities to industry and civil society on their work and priorities related to nanomaterials on the EU market.
Join the conversation by commenting on the posts.
Want to write a nanopinion post? Contact us.